Zodiac Passa

Zodiac Passa is a prominent Brazilian pharmaceutical company established in 1986, dedicated to delivering innovative and high-quality therapeutic solutions. For over three decades, the company has focused on enhancing patient quality of life across Brazil by promoting access to advanced treatments through internal development and strategic licensing agreements. Zodiac Passa aims to be the leading pharmaceutical entity in the country, cultivating an environment conducive to employee professional development while consistently introducing novel medical interventions. The company operates with a substantial workforce, ranging between 500 and 1,000 employees, underscoring its significant operational scale within the healthcare sector.

The organization actively supports both domestic and international partners, facilitating the expanded promotion and distribution of their pharmaceutical products throughout Latin America. This collaborative approach allows Zodiac Passa to leverage its market expertise and infrastructure to bring vital treatments to a wider patient population. The company's commitment extends to fostering a culture of innovation and growth, as evidenced by its vision to lead the Brazilian pharmaceutical market. Meet Zodiac Passa's team to learn more about their leadership and operational structure.

With a reported revenue of $71.6M, Zodiac Passa demonstrates robust financial performance, enabling continued investment in research, development, and market expansion. Its strategic focus on patient well-being and market leadership positions it as a key player in the Brazilian healthcare landscape. The company's product portfolio, including 'zodiac', reflects its dedication to addressing diverse medical needs and contributing to public health advancements within the region.